Journal Home > Volume 9 , Issue 3

The immature fruits of Poncirus trifoliate are used as a medicine for the treatment of gastrointestinal disorders, inflammation, and allergies in East Asia. However, their effect on colon cancer cells remains unclear. We investigated the effect of the immature fruit of P. trifoliate extract on colorectal adenocarcinoma. The extract of the immature fruit of P. trifoliata inhibited the proliferation of CT-26 cells compared with untreated cells and it induced autophagy and apoptosis through the protein kinase B/mammalian target of rapamycin and 5′-AMP-activated protein kinase pathways. The number of autophagic vacuoles and autophage markers increased in response to the extract. At later time-points, apoptosis increased dose/time-dependently. In CT-26 cells pre-treated a pan-caspase inhibitor prior to P. trifoliata immature fruit extract treatment, we did not find any change in pro-caspase 3 and pro-PARP levels. Additionally, in cells pre-treated autphage inhibitor, SQSTM1/p62 and LC3AB, pro-caspase 3 and pro-PARP levels did not change. Our results indicate the molecular mechanisms that the extract of the immature fruit of P. trifoliata induces apoptosis in colorectal carcinoma cells by inducing mitochondrial autophagy. In this study, we provided a draft for further investigate the use of MEPT for colorectal cancer inhibition.


menu
Abstract
Full text
Outline
About this article

The extract of the immature fruit of Poncirus trifoliata induces apoptosis in colorectal cancer cells via mitochondrial autophagy

Show Author's information Sun-Young KimaHo-Keun YibBong-Sik YuncDae-Yeol Leea,dPyung Han Hwanga,dHae-Ryong ParkeMin Sun Kima,d( )
Research Institute of Clinical Medicine of Jeonbuk National University, Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, 54907, South Korea
Department of Oral Biochemistry, Institute of Oral Bioscience, School of Dentistry, Jeonbuk National University, Jeonju, 54907, South Korea
Division of Biotechnology and Advanced Institute of Environment and Bioscience, Jeonbuk National University, Iksan-si, 54596, South Korea
Department of Pediatrics, Jeonbuk National University Medical School, Jeonju, 54907, South Korea
Department of Food Science and Biotechnology, Kyungnam University, Changwon-si, 51767, South Korea

Abstract

The immature fruits of Poncirus trifoliate are used as a medicine for the treatment of gastrointestinal disorders, inflammation, and allergies in East Asia. However, their effect on colon cancer cells remains unclear. We investigated the effect of the immature fruit of P. trifoliate extract on colorectal adenocarcinoma. The extract of the immature fruit of P. trifoliata inhibited the proliferation of CT-26 cells compared with untreated cells and it induced autophagy and apoptosis through the protein kinase B/mammalian target of rapamycin and 5′-AMP-activated protein kinase pathways. The number of autophagic vacuoles and autophage markers increased in response to the extract. At later time-points, apoptosis increased dose/time-dependently. In CT-26 cells pre-treated a pan-caspase inhibitor prior to P. trifoliata immature fruit extract treatment, we did not find any change in pro-caspase 3 and pro-PARP levels. Additionally, in cells pre-treated autphage inhibitor, SQSTM1/p62 and LC3AB, pro-caspase 3 and pro-PARP levels did not change. Our results indicate the molecular mechanisms that the extract of the immature fruit of P. trifoliata induces apoptosis in colorectal carcinoma cells by inducing mitochondrial autophagy. In this study, we provided a draft for further investigate the use of MEPT for colorectal cancer inhibition.

Keywords: Mitochondria, Autophagy, Apoptosis, Anticancer, Poncirus trifoliata

References(33)

[1]
World Health Organization, Cancer, 2018, Accessed November 5, 2018 http://www.who.int/news-room/fact-sheets/detail/cancer.
[2]

P. You, H. Wu, M. Deng, et al., Brevilin A. induces apoptosis and autophagy of colon adenocarcinoma cell CT26 via mitochondrial pathway and PI3K/AKT/mTOR inactivation, Biomed. Pharmacother. 98 (2018) 619-625, http://doi.org/10.1016/j.biopha.2017.12.057.

[3]

N. Sharma, J.P. Bhattarai, S.Y. Kim, et al., Effects of cisplatin on potassium currents in CT26 cells, J. Cancer Res. Ther. 12 (2016) 248-253, http://doi.org/10.4103/0973-1482.154085.

[4]

S. Kuntz, U. Wenzel, H. Daniel, Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines, Eur. J. Nutr. 38 (1999) 133-142, http://doi.org/10.1007/s003940050054.

[5]

P. Prakash, R.M. Russell, N.I. Krinsky, In vitro inhibition of proliferation of estrogen-dependent and estrogen-independent human breast cancer cells treated with carotenoids or retinoids, J. Nutr. 131 (2001) 1574-1580.

[6]

B.Y. Kim, H.Y. Yoon, S.I. Yun, et al., In vitro and in vivo inhibition of glucocorticoid-induced osteoporosis by the hexane extract of Poncirus trifoliata, Phytother. Res. 25 (2011) 1000-1010, http://doi.org/10.1002/ptr.3373.

[7]

H.Y. Han, M.H. Ryu, Y. Son, et al., Poncirus trifoliata Rafin. induces the apoptosis of triple-negative breast cancer cells via activation of the c-Jun NH(2)-terminal kinase and extracellular signal-regulated kinase pathways, Pharmacogn. Mag. 11 (2015) 237-243, http://doi.org/10.4103/0973-1296.166056.

[8]

W.Y. Jeon, O.S. Kim, C.S. Seo, et al., Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats, BMC Complement. Altern. Med. 17 (2017) 384, http://doi.org/10.1186/s12906-017-1877-y.

[9]

I.J. Lee, G.H. Xu, J.H. Ju, et al., 21-Methylmelianodiols from Poncirus trifoliata as inhibitors of interleukin-5 bioactivity in pro-B cells, Planta Med. 74 (2008) 396-400, http://doi.org/10.1055/s-2008-1034329.

[10]

J.M. Yi, M.S. Kim, H.N. Koo, et al., Poncirus trifoliata fruit induces apoptosis in human promyelocytic leukemia cells, Clin. Chim. Acta 340 (2004) 179-185, http://doi.org/10.1016/j.cccn.2003.10.017.

[11]

L. Yang, Y. Liu, M. Wang, et al., Celastrus orbiculatus extract triggers apoptosis and autophagy via PI3K/Akt/mTOR inhibition in human colorectal cancer cells, Oncol. Lett. 12 (2016) 3771-3778, http://doi.org/10.3892/ol.2016.5213.

[12]

F. Xu, J. Zang, D. Chen, et al., Neohesperidin induces cellular apoptosis in human breast adenocarcinoma MDA-MB-231 cells via activating the Bcl-2/Bax-mediated signaling pathway, Nat. Prod. Commun. 7 (2012) 1475-1478, http://doi.org/10.1177/1934578X1200701116.

[13]

J. Hong, H.Y. Min, G.H. Xu, et al., Growth inhibition and G1 cell cycle arrest mediated by 25-methoxyhispidol A, a novel triterpenoid, isolated from the fruit of Poncirus trifoliata in human hepatocellular carcinoma cells, Planta Med. 74 (2008) 151-155, http://doi.org/10.1055/s-2008-1034286.

[14]

A. Rahman, S.A. Siddiqui, R. Jakhar, et al., Growth inhibition of various human cancer cell lines by imperatorin and limonin from Poncirus trifoliata Rafin, Seeds. Anticancer. Agents. Med. Chem. 15 (2015) 236-241, http://doi.org/10.2174/1871520614666140922122358.

[15]

H.Y. Han, B.S. Park, G.S. Lee, et al., Autophagic cell death by Poncirus trifoliata Rafin., a traditional oriental medicine, in human oral cancer HSC-4 cells, Evid. Complement. Alternat. Med. (2015) 394263, http://doi.org/10.1155/2015/394263.

[16]

Y.R. Pokharel, E.H. Han, J.Y. Kim, et al., Potent protective effect of isoimperatorin against aflatoxin B1-inducible cytotoxicity in H4IIE cells: bifunctional effects on glutathione S-transferase and CYP1A, Carcinogenesis 27 (2006) 2483-2490, http://doi.org/10.1093/carcin/bgl118.

[17]

J.C. Castle, M. Loewer, S. Boegel, Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma, BMC Genom. 1 (2014) 190, http://doi.org/10.1186/1471-2164-15-190.

[18]

O.I. Hoffmann, C. Ilmberger, S. Magosch, et al., Impact of the spheroid model complexity on drug response, J. Biotechnol. 205 (2015) 14-23.

[19]

S. Wullschleger, R. Loewith, M.N. Hall, TOR signaling in growth and metabolism, Cell. 124 (2006) 471-484, http://doi.org/10.1016/j.cell.2006.01.016.

[20]

Z. Xie, D.J. Klionsky, Autophagosome formation: core machinery and adaptations, Nat. Cell Biol. 9 (2007) 1102-1109, http://doi.org/10.1038/ncb1007-1102.

[21]

W.L. Sun, D. Lan, T.Q. Gan, et al., Autophagy facilitates multidrug resistance development through inhibition of apoptosis in breast cancer cells, Neoplasma 62 (2015) 199-208, http://doi.org/10.4149/neo_2015_025.

[22]

A. Alayev, S.M. Berger, M.Y. Kramer, et al., The combination of rapamycin and resveratrol blocks autophagy and induces apoptosis in breast cancer cells, J. Cell. Biochem. 116 (2015) 450-457, http://doi.org/10.1002/jcb.24997.

[23]

X. Song, S.Y. Kim, L. Zhang, et al., Role of AMP-activated protein kinase in cross-talk between apoptosis and autophagy in human colon cancer, Cell Death Dis. 5 (2014) e1504, http://doi.org/10.1038/cddis.2014.463.

[24]

Y.G. Shi, A structure view of mitochondria-mediated apoptosis, Nat. Struct. Biol. 8 (2001) 394-401.

[25]

L. Žiberna, D. Šamec, A. Mocan, et al., Oleanolic acid alters multiple cell signaling pathways: implication in cancer prevention and therapy, Int. J. Mol. Sci. 16 (2017), Article E643.

[26]

D. Heras-Sandoval, J.M. Pérez-Rojas, J. Hernández-Damián, et al., The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration, Cell. Signal. 26 (2014) 2694-2701, http://doi.org/10.1016/j.cellsig.2014.08.019.

[27]

M. Liu, C.M. Li, Z.F. Chen, et al., Celecoxib regulates apoptosis and autophagy via the PI3K/Akt signaling pathway in SGC-7901 gastric cancer cells, Int. J. Mol. Med. 33 (2014) 1451-1458, http://doi.org/10.3892/ijmm.2014.1713.

[28]

C. Wang, X. Zhang, Z. Teng, et al., Downregulation of PI3K/Akt/mTOR signaling pathway in curcumin-induced autophagy in APP/PS1 double transgenic mice, Eur. J. Pharmacol. 740 (2014) 312-320, http://doi.org/10.1016/j.ejphar.2014.06.051.

[29]

D.J. Klionsky, The molecular machinery of autophagy: unanswered questions, J. Cell. Sci. 118 (2005) 7-18, http://doi.org/10.1242/jcs.01620.

[30]

S. Wu, C. Sun, D. Tian, et al., Expression and clinical significances of Beclin1, LC3 and mTOR in colorectal cancer, Int. J. Clin. Exp. Pathol. 8 (2015) 3882-3891.

[31]

Z. Cai, J. Ke, X. He, et al., Significance of mTOR signaling and its inhibitor against cancer stem-like cells in colorectal cancer, Ann. Surg. Oncol. 21 (2014) 179-188, http://doi.org/10.1245/s10434-013-3146-8.

[32]

A. Eisenberg-Lerner, S. Bialik, H.U. Simon, et al., Life and death partners: apoptosis, autophagy and the cross-talk between them, Cell Death Differ. 16 (2009) 966-975, http://doi.org/10.1038/cdd.2009.33.

[33]

J. Chen, Z. Wang, S. Yu, AIM2 regulates viability and apoptosis in human colorectal cancer cells via the PI3K/Akt pathway, Onco. Ther. 10 (2017) 811-817, http://doi.org/10.2147/OTT.S125039.

Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 23 October 2019
Revised: 10 April 2020
Accepted: 07 May 2020
Published: 15 May 2020
Issue date: September 2020

Copyright

© 2020 "Society information". Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.

Acknowledgements

This work was supported by Fund of Biomedical Research Institute, Jeonbuk National University Hospital.

Rights and permissions

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return